Literature DB >> 34140180

The impact of marital status on stage at diagnosis and survival of female patients with breast and gynecologic cancers: A meta-analysis.

Ruixia Yuan1, Chao Zhang2, Qi Li3, Mei Ji4, Nannan He5.   

Abstract

The aim of this meta-analysis is to evaluate the effect of marital status on the stage at diagnosis and survival of female patients with breast and gynecologic cancers. A systematic literature search was conducted on electronic databases (PubMed, Cochrane and EMBASE) till December 31, 2020. Publications investigating the association of marital status with stage at diagnosis and/or cancer-specific mortality (CSM) and/or overall survival (OS) in female patients with breast or gynecologic cancers were retrieved. After studies were selected according to inclusion criteria, data extraction, quality assessment and data analysis were performed. 55 articles were eligible for inclusion, consisting of 1,195,773 female cancer patients with breast, vulvar, cervical, endometrial and ovarian cancers. Unmarried female cancer patients had higher odds of being diagnosed at later stage [odds ratio (OR) = 1.28, 95% confidence interval (CI): 1.22-1.36)] and worse survival outcomes in CSM [hazard ratio (HR) = 1.22, 95% CI: 1.16-1.28] and OS (HR = 1.20, 95% CI: 1.14-1.25). This estimate did not vary by level of social support, number of adjustment factors, or between America and Europe. Being married is associated with timely diagnosis and favorable prognosis in most women's cancers. Unmarried female cancer patients have a higher risk of late-stage diagnosis and worse survival outcomes than the married. Greater concern shall be demonstrated towards unmarried female cancer patients. Furthermore, the impact of lacking economic and emotional support on survival outcomes in unmarried female cancer patients deserves particular attention.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Cancer-specific mortality; Gynecologic cancer; Marital status; Overall survival; Stage at diagnosis

Mesh:

Year:  2021        PMID: 34140180     DOI: 10.1016/j.ygyno.2021.06.008

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  2 in total

1.  Clinical features and prognostic indicators in upper-tract urothelial carcinoma with bone metastasis.

Authors:  Mingping Zhou; Jianxin Zhang; Xiaowei Chen; Zhan Wang; Wei Liang
Journal:  Front Surg       Date:  2022-08-30

2.  Cause of Death During Renal Cell Carcinoma Survivorship: A Contemporary, Population-Based Analysis.

Authors:  Dong-Dong Yu; Wei-Kang Chen; Chen-Yu Wu; Wan-Ting Wu; Xiao Xin; Yu-Li Jiang; Peng Li; Ming-Hua Zhang
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.